Based on the above deduction, we observed whether the inhibitor of GSDMD, NSA, could reduce the release of TNF-α and prevent the reduction of NK cell depletion to enhance the body’s ability to resist infections and to alleviate the lung tissue damage induced by PRV infection. Here, TNF is linked to infection.